Celcuity (CELC) 5K contracts of April 130 calls trade Mar 2, 2026 02:39PM
Wolfe Research: 'We'd be buyers of CELC on any weakness related to the external catalyst' Feb 4, 2026 09:58AM
Celcuity receives FDA acceptance for gedatolisib breast cancer drug Jan 20, 2026 07:30AM
Jefferies lists 5 biotech M&A candidates for 2026 Dec 23, 2025 05:30PM
Celcuity Inc (CELC) PT Raised to $118 at Leerink Partners Dec 17, 2025 04:02AM


Dec 12, 2025 05:22AM Wells Fargo Starts Celcuity Inc (CELC) at Overweight
Dec 1, 2025 05:10PM Celcuity Inc (CELC) PT Raised to $134 at Jefferies
Nov 25, 2025 11:15AM Jefferies on Celcuity Inc (CELC): 'we believe everolimus+gire could be a good option specifically for the PIK3CAwt/ESR1mut subgrp'
Nov 18, 2025 11:50AM Increasing unusual call option volume: EQG CELC BBD FE CWAN
Nov 17, 2025 04:11PM Wolfe Research Starts Celcuity Inc (CELC) at Outperform
Nov 17, 2025 06:23AM H.C. Wainwright Downgrades Celcuity Inc (CELC) to Neutral
Nov 13, 2025 04:45AM Celcuity Inc (CELC) PT Raised to $115 at Stifel
Nov 12, 2025 04:13PM Celcuity (CELC) Tops Q3 EPS by 10c
Oct 30, 2025 10:41AM Increasing unusual call option volume: BBD BORR APLS VIAV ROIV FMC VITL RSI METU OWL FBL FI CELC
Sep 22, 2025 02:23AM Guggenheim Starts Celcuity Inc (CELC) at Buy
Sep 9, 2025 04:01PM Celcuity increases term loan facility to $500 million
Aug 18, 2025 06:47AM Celcuity Inc (CELC) PT Raised to $66 at H.C. Wainwright
Aug 15, 2025 11:47AM Celcuity Inc (CELC) PT Raised to $68 at Stifel
Aug 15, 2025 07:08AM Celcuity Inc (CELC) PT Lowered to $70 at Needham
Aug 15, 2025 05:08AM Celcuity Inc (CELC) PT Raised to $79 at Jefferies
Aug 14, 2025 04:02PM Celcuity (CELC) Misses Q2 EPS by 16c
Jul 29, 2025 06:41AM Celcuity Inc (CELC) PT Raised to $50 at H.C. Wainwright
Jul 14, 2025 07:06AM Celcuity receives patent extending gedatolisib exclusivity to 2042
Jul 1, 2025 05:18AM Stifel Assumes Celcuity (CELC) at Buy
Jun 30, 2025 07:05AM Celcuity (CELC) Reports Clinical Data from Two Early Phase Studies of Gedatolisib
May 14, 2025 04:04PM Celcuity (CELC) Misses Q1 EPS by 14c
Apr 1, 2025 09:16AM Stifel Reiterates Buy Rating on Celcuity Inc (CELC)
Mar 31, 2025 04:01PM Celcuity (CELC) Misses Q4 EPS by 4c
Jan 23, 2025 07:27AM Celcuity Inc (CELC) PT Raised to $33 at Jefferies
Dec 11, 2024 07:05AM Celcuity (CELC) Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy
Nov 14, 2024 04:01PM Celcuity (CELC) Reports In-Line Q3 EPS
Oct 7, 2024 06:29AM Celcuity Inc (CELC) PT Raised to $42 at Stifel
Aug 15, 2024 09:24AM TD Cowen Reiterates Buy Rating on Celcuity Inc (CELC)
Aug 15, 2024 08:10AM Celcuity Inc (CELC) PT Lowered to $39 at Stifel
Aug 14, 2024 04:02PM Celcuity (CELC) Tops Q2 EPS by 10c
Jul 22, 2024 02:43PM Celcuity Inc (CELC) PT Lowered to $68 at Jefferies